Riskpilot← Back to searchSign inGet full accessAvia Pharma Oy
OYActiveY-tunnus 2077990-4Pakkalankuja 6Wholesale of pharmaceutical and medical goods · NACE 4646Est. 2006— employeeswww.decempharma.fi
Revenue 2024
EUR 3,1M
+3% vs 2023
EBITDA margin
18.2%
-2% vs 2023
Equity ratio
88.3%
Financial strength
Net profit 2024
EUR 352K
-3% vs 2023
| Revenue | EUR 3,1M | +3% |
| EBITDA | EUR 561K | -2% |
| Net profit | EUR 352K | -3% |
| Total assets | EUR 2M | +2% |
| Equity | EUR 1,8M | +24% |
| Employees | — | — |
Legal name
Avia Pharma Oy
Y-tunnus number
2077990-4
Legal form
Osakeyhtiö
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
30. marraskuuta 2006
Share capital
EUR 2 550
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Lääkkeiden, rohdosvalmisteiden, ravintolisien ja yleisten kauppatavaroiden valmistaminen, maahantuonti sekä myynti ja markkinointi. Yhtiö voi myös sopimusvalmistuttaa tuotteita. Yhtiö tekee tutkimuksia, se voi omistaa ja hallita irtainta ja kiinteää omaisuutta, oikeuksia, osuuksia ja arvopapereita sekä käydä niillä kauppaa. Yhtiö voi harjoittaa tuonti-, vienti- ja agentuuritoimintaa.
Address
Pakkalankuja 6
Phone
+358504305992
Email
info@decempharma.fi
Website
www.decempharma.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 15 059 | 6 484 | 3 578 | 2 981 | 3 081 |
| Staff expenses | −274 | −329 | −249 | −212 | −235 |
| EBITDA | 3 396 | 5 738 | 942 | 574 | 561 |
| Depreciation & amort. | −98 | −77 | −5 297 | −110 | −116 |
| EBIT | 3 298 | 5 661 | −4 355 | 464 | 445 |
| Net financials | −62 | −71 | −13 | −3 | −3 |
| Profit before tax | 3 236 | 5 590 | −4 368 | 461 | 442 |
| Tax | 647 | 73 | 22 | 98 | 90 |
| Net profit | 2 589 | 5 517 | −4 390 | 363 | 352 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 948 | 6 867 | 2 016 | 2 014 | 2 048 |
| Equity | 3 425 | 5 741 | 1 093 | 1 456 | 1 808 |
| Long-term debt | 94 | 28 | 750 | 250 | 0 |
| Short-term debt | 427 | 1 099 | 173 | 308 | 240 |
| Total debt | 521 | 1 126 | 923 | 558 | 240 |
EBITDA margin
18.2%
This company
15.8%
Market median
+15% vs market
20202024
Equity ratio
88.3%
This company
38.2%
Market median
+131% vs market
20202024
Return on equity
19.5%
This company
18.4%
Market median
+6% vs market
20202024
Net profit margin
11.4%
This company
8.1%
Market median
+41% vs market
20202024
Asset turnover
1.50×
This company
1.12×
Market median
+34% vs market
20202024
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-12-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2020-12-01 – 2021-11-30
- Annual report 2020Filed via PRH / YTJ · Period 2019-12-01 – 2020-11-30
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
TJ Audit | Audit | 2018 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2022 | |
| Chairperson | 2022 | |
| Board of Directors | 2024 | |
| Board of Directors | 2022 | |
| Former (2) | ||
| Board of Directors | 2016 – 2023 | |
| Board of Directors | 2016 – 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Avia Pharma Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Turo Juhani Koila | Audit | 0 companies |
| Jonas Bo Karlander | Board of Directors | 0 companies |
| Tero Tapani Weckroth | Board of Directors | 0 companies |
| Jacob Christoffer Calmvik | Chairperson | 0 companies |
| Harri Kristian Eskelin | Board of Directors | 0 companies |
| Tero Olavi Purra | Board of Directors | 0 companies |
| Erno Johannes Lehtovirta | Board of Directors | 0 companies |